FREAC3 Polyclonal Antibody
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


FREAC3 Polyclonal Antibody
Background:
Binding of FREAC-3 and FREAC-4 to their cognate sites results in bending of the DNA at an angle of 80-90 degrees. Involvement in disease; Defects in FOXC1 are the cause of Axenfeld-Rieger syndrome type 3 (RIEG3) ; also known as Axenfeld-Rieger syndrome (ARS) or Axenfeld syndrome or Axenfeld anomaly. It is characterized by posterior corneal embryotoxon, prominent Schwalbe line and iris adhesion to the Schwalbe line. Other features may be hypertelorism (wide spacing of the eyes), hypoplasia of the malar bones, congenital absence of some teeth and mental retardation. When associated with tooth anomalies, the disorder is known as Rieger syndrome. Glaucoma is a progressive blinding condition that occurs in approximately half of patients with Axenfeld-Rieger malformations.Synonyms:
ARA; FKH L7; FKHL 7; FKHL7; Forkhead (Drosophila) like 7; Forkhead; forkhead box C1; Forkhead box protein C1; Forkhead drosophila homolog like 7; Forkhead like 7; Forkhead related activator 3; Forkhead related protein FKHL7; Forkhead related transcription factor 3; Forkhead-related protein FKHL7; Forkhead-related transcription factor 3; FOX C1; FOXC 1; FOXC1; FOXC1_HUMAN; FREAC 3; FREAC-3; FREAC3; homolog-like 7; IGDA; IHG 1; IHG1; IRID 1; IRID1; Iridogoniodysgenesis type 1; Myeloid factor delta.,Gene ID:
2296Swiss Prot:
Q12948Host:
RabbitCross Reactivity:
Human, Mouse, RatImmunogen:
201-300/553Target:
FREAC3Clonality:
PolyclonalIsotype:
IgGConjugation:
UnconjugatedSource:
KLH conjugated synthetic peptide derived from human FREAC3Applications:
WB, Flow-CytPurification:
Purified by Protein A.Concentration:
1µg/µlDilution:
WB (WB=1:500-2000), Flow-Cyt (Flow-Cyt=1ug/Test)Buffer:
0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.Modification:
UnmodifiedStorage Conditions:
Store at -20°C for 12 months.Gene ID URL:
2296
